Drug Shortage Report for TEVA-ECTOSONE
Report ID | 144715 |
Drug Identification Number | 00653217 |
Brand name | TEVA-ECTOSONE |
Common or Proper name | TEVA-ECTOSONE |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | BETAMETHASONE |
Strength(s) | 0.1% |
Dosage form(s) | LOTION |
Route of administration | TOPICAL TOPICAL |
Packaging size | 75 |
ATC code | D07AC |
ATC description | CORTICOSTEROIDS, PLAIN |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2021-08-27 |
Estimated end date | 2023-11-30 |
Actual end date | 2023-11-30 |
Shortage status | Resolved |
Updated date | 2023-12-05 |
Company comments | This pack size is now discontinued, and no longer available. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2021-08-27 | English | Compare |
v2 | 2021-08-27 | French | Compare |
v3 | 2021-08-28 | English | Compare |
v4 | 2021-10-07 | English | Compare |
v5 | 2021-10-07 | French | Compare |
v6 | 2021-12-22 | English | Compare |
v7 | 2021-12-22 | French | Compare |
v8 | 2022-02-10 | English | Compare |
v9 | 2022-02-10 | French | Compare |
v10 | 2022-03-24 | English | Compare |
v11 | 2022-03-24 | French | Compare |
v12 | 2022-08-18 | English | Compare |
v13 | 2022-08-18 | French | Compare |
v14 | 2022-12-01 | English | Compare |
v15 | 2022-12-01 | French | Compare |
v16 | 2023-04-27 | English | Compare |
v17 | 2023-04-27 | French | Compare |
v18 | 2023-10-03 | English | Compare |
v19 | 2023-10-03 | French | Compare |
v20 | 2023-12-05 | English | Compare |